Regulation of oligodendrocyte differentiation: protein kinase C activation prevents differentiation of O2A progenitor cells toward oligodendrocytes - PubMed (original) (raw)

Regulation of oligodendrocyte differentiation: protein kinase C activation prevents differentiation of O2A progenitor cells toward oligodendrocytes

W Baron et al. Glia. 1998 Feb.

Abstract

Oligodendrocytes differentiate on a specific schedule in vivo in order to myelinate axons at the precise time and at the appropriate position. The current study was undertaken to obtain further insight as to how this timed appearance is regulated intracellularly. We observed that exposure of O2A progenitor cells in culture to phorbol 12-myristate 13-acetate (PMA; an activator of protein kinase C, PKC) inhibited their differentiation to oligodendrocytes by suppressing the expression of specific myelin markers at the O4-stage. To positively identify a role of PKC per se in differentiation, the use of a minimal medium with low serum content turned out to be essential. This was demonstrated by showing that the inhibitory effect of PMA on oligodendrocyte differentiation could be completely abolished by a combined action of insulin, triiodothyronine (T3), hydrocortisone and other components of a chemically defined medium (CDM). Furthermore, the PMA-mediated inhibition of oligodendrocyte differentiation could be partially restored by activation of the cAMP signal transduction pathway. The results indicate that PKC plays a crucial role in the differentiation of O2A progenitor cells toward oligodendrocytes: PKC activation prevents differentiation of O2A progenitor cells, whereas differentiation toward oligodendrocytes is dependent on other signaling compounds which may counteract the PKC signal transduction route.

PubMed Disclaimer

Cited by

Antioxidant, Anti-Inflammatory and Pro-Differentiative Effects of Chlorogenic Acid on M03-13 Human Oligodendrocyte-like Cells.
La Rosa G, Sozio C, Pipicelli L, Raia M, Palmiero A, Santillo M, Damiano S. La Rosa G, et al. Int J Mol Sci. 2023 Nov 24;24(23):16731. doi: 10.3390/ijms242316731. Int J Mol Sci. 2023. PMID: 38069054 Free PMC article.
Huntington disease oligodendrocyte maturation deficits revealed by single-nucleus RNAseq are rescued by thiamine-biotin supplementation.
Lim RG, Al-Dalahmah O, Wu J, Gold MP, Reidling JC, Tang G, Adam M, Dansu DK, Park HJ, Casaccia P, Miramontes R, Reyes-Ortiz AM, Lau A, Hickman RA, Khan F, Paryani F, Tang A, Ofori K, Miyoshi E, Michael N, McClure N, Flowers XE, Vonsattel JP, Davidson S, Menon V, Swarup V, Fraenkel E, Goldman JE, Thompson LM. Lim RG, et al. Nat Commun. 2022 Dec 21;13(1):7791. doi: 10.1038/s41467-022-35388-x. Nat Commun. 2022. PMID: 36543778 Free PMC article.
Neural Epidermal Growth Factor-Like Like Protein 2 Is Expressed in Human Oligodendroglial Cell Types.
Shaker MR, Kahtan A, Prasad R, Lee JH, Pietrogrande G, Leeson HC, Sun W, Wolvetang EJ, Slonchak A. Shaker MR, et al. Front Cell Dev Biol. 2022 Feb 21;10:803061. doi: 10.3389/fcell.2022.803061. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35265611 Free PMC article.
The MAL Protein, an Integral Component of Specialized Membranes, in Normal Cells and Cancer.
Rubio-Ramos A, Labat-de-Hoz L, Correas I, Alonso MA. Rubio-Ramos A, et al. Cells. 2021 Apr 30;10(5):1065. doi: 10.3390/cells10051065. Cells. 2021. PMID: 33946345 Free PMC article. Review.
5-Hydroxytryptamine Modulates Maturation and Mitochondria Function of Human Oligodendrocyte Progenitor M03-13 Cells.
Damiano S, La Rosa G, Sozio C, Cavaliere G, Trinchese G, Raia M, Paternò R, Mollica MP, Avvedimento VE, Santillo M. Damiano S, et al. Int J Mol Sci. 2021 Mar 5;22(5):2621. doi: 10.3390/ijms22052621. Int J Mol Sci. 2021. PMID: 33807720 Free PMC article.

Regulation of oligodendrocyte differentiation: protein kinase C activation prevents differentiation of O2A progenitor cells toward oligodendrocytes - PubMed (original) (raw)